Literature DB >> 20298436

Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway.

Kanako Kume1, Yosuke Iizumi, Masashi Shimada, Yuki Ito, Tsutomu Kishi, Yuki Yamaguchi, Hiroshi Handa.   

Abstract

Of 20 natural amino acids, leucine is particularly important for promoting cellular protein synthesis. The effect of leucine involves mammalian target of rapamycin (mTOR), a key protein kinase controlling cell growth. Leucine enhances mTOR-mediated phosphorylation of S6K1 and 4E-BP, thereby promoting protein synthesis. However, how the presence of leucine is sensed and transmitted to mTOR is poorly understood. Here, we show evidence that UBR1 and UBR2 might be cellular targets of leucine. UBR1 and UBR2 are E3 ubiquitin ligases that recognize the identity of N-terminal residues and contribute to selective destabilization of target proteins according to the N-end rule. Using leucine-immobilized affinity beads, we identified UBR1 and UBR2 as leucine-binding proteins from leucine-responsive rat hepatoma H4IIE cells. Over-expression of UBR1 or UBR2 resulted in a reduction in mTOR-dependent S6K1 phosphorylation, whereas knockdown of UBR1 or UBR2 increased S6K1 phosphorylation in amino acid-starved human 293T cells. We also found that leucine binds to the substrate-recognition domain of UBR2 and inhibits degradation of N-end rule substrates in vitro. These findings suggest that UBR1 and UBR2 are negative regulators of the leucine-mTOR signaling pathway. Leucine might activate this pathway in part through inhibition of their ubiquitin ligase activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298436     DOI: 10.1111/j.1365-2443.2010.01385.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  17 in total

1.  Ser(120) of Ubc2/Rad6 regulates ubiquitin-dependent N-end rule targeting by E3{alpha}/Ubr1.

Authors:  Brajesh Kumar; Kimberly G Lecompte; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 2.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

3.  Identification of novel mutations by exome sequencing in African American colorectal cancer patients.

Authors:  Hassan Ashktorab; Mohammad Daremipouran; Joe Devaney; Sudhir Varma; Hamed Rahi; Edward Lee; Babak Shokrani; Russell Schwartz; Michael L Nickerson; Hassan Brim
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

Review 4.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

Review 5.  DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors:  Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

6.  Genomics of Colorectal Cancer in African Americans.

Authors:  Hassan Brim; Hassan Ashktorab
Journal:  Next Gener Seq Appl       Date:  2016-09-21

7.  The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin.

Authors:  Hao Xu; Jianjin Shi; Hang Gao; Ying Liu; Zhenxiao Yang; Feng Shao; Na Dong
Journal:  EMBO J       Date:  2019-05-06       Impact factor: 11.598

Review 8.  Role of amino acid transporters in amino acid sensing.

Authors:  Peter M Taylor
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

9.  UBR1 promotes protein kinase quality control and sensitizes cells to Hsp90 inhibition.

Authors:  Rasheda Sultana; Maria A Theodoraki; Avrom J Caplan
Journal:  Exp Cell Res       Date:  2011-09-29       Impact factor: 3.905

10.  A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.

Authors:  Stephanie Hiu Ling Poon; Janice Jing-Chee Cheung; Kendrick Co Shih; Yau Kei Chan
Journal:  Rev Endocr Metab Disord       Date:  2022-01-23       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.